跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,751 条关于
“Cholesterol Efflux”
全部
2,751
临床试验
2,120
药物
47
机构
1
资讯
583
去年
ZyVersa Therapeutics to Present Kidney Disease Drug VAR 200 at JPM Healthcare Conference 2025
去年
ZyVersa Therapeutics Initiates Phase 2a Trial for First-in-Class Diabetic Kidney Disease Treatment VAR 200
去年
TREM2 Emerges as Dual Regulator of Lipid Metabolism and Immune Response in MASH
3个月前
MediciNova Completes Phase 2 Trial of Tipelukast for NAFLD and Hypertriglyceridemia in Type 2 Diabetes
去年
FDA Authorizes Emergency Compassionate Use of VAR 200 for Ultra-Rare ApoCII Amyloidosis
10个月前
Lipid Metabolism Emerges as Key Target for Cancer Immunotherapy Enhancement
11个月前
Precision Immunomodulation Emerges as Key Strategy to Balance Inflammation and Restore Tissue Homeostasis
去年
ZyVersa's IC 100 Shows Promise as Disease-Modifying Treatment for Parkinson's Disease
去年
TAXIS Pharmaceuticals Receives FDA QIDP Designation for TXA14007 Efflux Pump Inhibitor to Combat Antibiotic-Resistant Pneumonia
去年
Landmark Study Challenges Decades of Cholesterol Concerns About Eggs
第 1 页,共 59 页
上一页
下一页